Barclays PLC
06 March 2008
6 March 2008
Director/PDMR Shareholding: Disclosure and Transparency Rules 3.1.4R(1)(a) and
3.1.4R(1)(b)
The independent trustee of the Barclays Group (ESAS) Employees' Benefit Trust
(the 'ESAS Trust') notified the Company on 5 March 2008 that it had on 4 March
2008 exercised its discretion and released a total of 1,106,348 ordinary shares
in Barclays PLC to the following Director of Barclays PLC, who is a participant
in the Executive Share Award Scheme ('ESAS'). The shares were released following
provisional allocations made by the trustee over Barclays PLC ordinary shares to
participants in the ESAS.
Director/PDMR Shares released Shares sold Price per Shares retained
to Director / on behalf of share (pence) by Director /
PDMR director to PDMR
satisfy
witholding
liabilities
Mr RE Diamond 1,106,348 468,085 453.75 638,263
Jr
The revised total shareholding following this transaction is as follows:
Director Beneficial Holding
Mr RE Diamond Jr 4,040,455
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.